A Phase 2, Open-Label Study of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer and Other Solid Tumors(TAMARACK)

Project: Research

Project Details

StatusActive
Effective start/end date7/06/236/06/25

Keywords

  • Clinical trials
  • CP-MGC018-03
  • Prostate cancer